MRVL vs RTX: Which Is the Better Buy?

Side-by-side comparison of Marvell Technology, Inc. and RTX Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
Marvell Technology, Inc. Β· Technology
$258.95
-11.4% upside to fair value
Med Conviction Grade C High Quality
VS
RTX Corporation Β· Industrials
$193.54
+33.0% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
RTX has more upside to fair value (+33.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MRVL RTX
Current Price $258.95 $193.54
Fair Value Estimate $229.46 $257.36
Upside to Fair Value -11.4% +33.0%
Market Cap $226.8B $260.9B
Forward P/E β€” β€”
EV / EBITDA 48.0x 18.1x
Price / Sales 24.0x 2.8x
Price / FCF 134.3x 21.7x
Revenue Growth YoY +36.5% +14.5%
Gross Margin 51.4% 20.3%
Operating Margin 16.7% 11.2%
Return on Equity 16.2% 11.8%
Dividend Yield 0.09% 1.46%
FCF Yield 0.74% 4.6%
Analyst Consensus Strong Buy Buy
Investment Thesis
MRVL β€” Marvell Technology, Inc.
Marvell Technology is a data infrastructure semiconductor specialist that designs custom AI accelerators, electro-optics DSPs, ethernet switching, storage controllers and interconnect silicon for hyperscale data centers, communications and carrier markets, employing roughly 7,480 people under CEO Matthew J. Murphy. Business quality is genuinely high on the demand side: revenue grew 36.5% year ove…
RTX β€” RTX Corporation
RTX Corporation is a $260.85 billion aerospace and defense conglomerate operating three segments β€” Collins Aerospace, Pratt & Whitney, and Raytheon β€” serving commercial aviation, military, and government customers worldwide with 180,000 employees. The business quality is high: it holds intangible-asset and switching-cost advantages rooted in long-cycle engine programs, proprietary defense electro…
Accumulation Zones
Metric MRVL RTX
Zone Low $172.09 $193.02
Zone High $195.04 $218.76
In Buy Zone? No Yes
← MRVL Research    RTX Research β†’    All Research